Report for Parnetti L

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (13)

Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122
Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K
Ref : Acta Neurologica Scandinavica , 124 :122 , 2011
Abstract : Parnetti_2011_Acta.Neurol.Scand_124_122
ESTHER : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122
PubMedID: 20880294

Title : Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? - Parnetti_2007_J.Neurol.Sci_257_264
Author(s) : Parnetti L , Mignini F , Tomassoni D , Traini E , Amenta F
Ref : Journal of Neurology Sci , 257 :264 , 2007
Abstract : Parnetti_2007_J.Neurol.Sci_257_264
ESTHER : Parnetti_2007_J.Neurol.Sci_257_264
PubMedSearch : Parnetti_2007_J.Neurol.Sci_257_264
PubMedID: 17331541

Title : A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance - Calabresi_2006_Lancet.Neurol_5_974
Author(s) : Calabresi P , Picconi B , Parnetti L , Di Filippo M
Ref : Lancet Neurol , 5 :974 , 2006
Abstract : Calabresi_2006_Lancet.Neurol_5_974
ESTHER : Calabresi_2006_Lancet.Neurol_5_974
PubMedSearch : Calabresi_2006_Lancet.Neurol_5_974
PubMedID: 17052664

Title : Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease - Lanari_2006_Mech.Ageing.Dev_127_158
Author(s) : Lanari A , Amenta F , Silvestrelli G , Tomassoni D , Parnetti L
Ref : Mech Ageing Dev , 127 :158 , 2006
Abstract : Lanari_2006_Mech.Ageing.Dev_127_158
ESTHER : Lanari_2006_Mech.Ageing.Dev_127_158
PubMedSearch : Lanari_2006_Mech.Ageing.Dev_127_158
PubMedID: 16297434

Title : Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease - Saez-Valero_2003_J.Neurosci.Res_72_520
Author(s) : Saez-Valero J , Fodero LR , Sjogren M , Andreasen N , Amici S , Gallai V , Vanderstichele H , Vanmechelen E , Parnetti L , Blennow K , Small DH
Ref : Journal of Neuroscience Research , 72 :520 , 2003
Abstract : Saez-Valero_2003_J.Neurosci.Res_72_520
ESTHER : Saez-Valero_2003_J.Neurosci.Res_72_520
PubMedSearch : Saez-Valero_2003_J.Neurosci.Res_72_520
PubMedID: 12704813

Title : Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors - Parnetti_2002_Neurol.Sci_23_S95
Author(s) : Parnetti L , Amici S , Lanari A , Romani C , Antognelli C , Andreasen N , Minthon L , Davidsson P , Pottel H , Blennow K , Gallai V
Ref : Neurol Sci , 23 :S95 , 2002
Abstract : Parnetti_2002_Neurol.Sci_23_S95
ESTHER : Parnetti_2002_Neurol.Sci_23_S95
PubMedSearch : Parnetti_2002_Neurol.Sci_23_S95
PubMedID: 12548360

Title : Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? - Tayebati_2001_J.Neuroimmunol_121_126
Author(s) : Tayebati SK , Amenta F , Amici S , El-Assouad D , Gallai V , Ricci A , Parnetti L
Ref : Journal of Neuroimmunology , 121 :126 , 2001
Abstract : Tayebati_2001_J.Neuroimmunol_121_126
ESTHER : Tayebati_2001_J.Neuroimmunol_121_126
PubMedSearch : Tayebati_2001_J.Neuroimmunol_121_126
PubMedID: 11730949

Title : Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? - Amenta_2001_Mech.Ageing.Dev_122_2025
Author(s) : Amenta F , Parnetti L , Gallai V , Wallin A
Ref : Mech Ageing Dev , 122 :2025 , 2001
Abstract : Amenta_2001_Mech.Ageing.Dev_122_2025
ESTHER : Amenta_2001_Mech.Ageing.Dev_122_2025
PubMedSearch : Amenta_2001_Mech.Ageing.Dev_122_2025
PubMedID: 11589920

Title : Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina - Amici_2001_Mech.Ageing.Dev_122_2057
Author(s) : Amici S , Lanari A , Romani R , Antognelli C , Gallai V , Parnetti L
Ref : Mech Ageing Dev , 122 :2057 , 2001
Abstract : Amici_2001_Mech.Ageing.Dev_122_2057
ESTHER : Amici_2001_Mech.Ageing.Dev_122_2057
PubMedSearch : Amici_2001_Mech.Ageing.Dev_122_2057
PubMedID: 11589922

Title : Therapeutic options in dementia - Parnetti_2000_J.Neurol_247_163
Author(s) : Parnetti L
Ref : Journal of Neurology , 247 :163 , 2000
Abstract : Parnetti_2000_J.Neurol_247_163
ESTHER : Parnetti_2000_J.Neurol_247_163
PubMedSearch : Parnetti_2000_J.Neurol_247_163
PubMedID: 10787108

Title : Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes - Tayebati_1999_J.Neuroimmunol_99_224
Author(s) : Tayebati SK , Codini M , Gallai V , Mannino F , Parnetti L , Ricci A , Sarchielli P , Amenta F
Ref : Journal of Neuroimmunology , 99 :224 , 1999
Abstract : Tayebati_1999_J.Neuroimmunol_99_224
ESTHER : Tayebati_1999_J.Neuroimmunol_99_224
PubMedSearch : Tayebati_1999_J.Neuroimmunol_99_224
PubMedID: 10505979

Title : Cognitive enhancement therapy for Alzheimer's disease. The way forward - Parnetti_1997_Drugs_53_752
Author(s) : Parnetti L , Senin U , Mecocci P
Ref : Drugs , 53 :752 , 1997
Abstract : Parnetti_1997_Drugs_53_752
ESTHER : Parnetti_1997_Drugs_53_752
PubMedSearch : Parnetti_1997_Drugs_53_752
PubMedID: 9129864

Title : Clinical pharmacokinetics of drugs for Alzheimer's disease - Parnetti_1995_Clin.Pharmacokinet_29_110
Author(s) : Parnetti L
Ref : Clinical Pharmacokinetics , 29 :110 , 1995
Abstract : Parnetti_1995_Clin.Pharmacokinet_29_110
ESTHER : Parnetti_1995_Clin.Pharmacokinet_29_110
PubMedSearch : Parnetti_1995_Clin.Pharmacokinet_29_110
PubMedID: 7586900